Lysophosphatidic acid signaling: How a small lipid does big things

Trends in Biochemical Sciences

Volumn 28, Issue 7, 2003, Pages 377-383

  Luquain, Celine ^a   Sciorra, Vicki A ^b   Morris, Andrew J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; LIPID; LYSOPHOSPHATIDIC ACID; RECEPTOR SUBTYPE;

CANCER GROWTH; CLINICAL PATHWAY; DISEASE COURSE; ENZYME ACTIVITY; EXTRACELLULAR SPACE; GENETIC TRANSCRIPTION; INTRACELLULAR SPACE; NERVE FUNCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0038487319     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(03)00139-7     Document Type: Review

References (49)

1. Moolenaar W.H. Development of our current understanding of bioactive lysophospholipids. Ann. N. Y. Acad. Sci. 905:2000;1-10.
2. Tigyi G. Physiological responses to lysophosphatidic acid and related glycero-phospholipids. Prostaglandins. 64:2001;47-62.
3. Lynch K.R., Im D.S. Life on the edg. Trends Pharmacol. Sci. 20:1999;473-475.
4. Hla T., et al. Lysophospholipids-receptor revelations. Science. 294:2001;1875-1878.
5. Fukushima N., et al. Lysophospholipid receptors. Annu. Rev. Pharmacol. Toxicol. 41:2001;507-534.
6. Hecht J.H., et al. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135:1996;1071-1083.
7. Fukushima N., et al. A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6151-6156.
8. An S., et al. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem. Biophys. Res. Commun. 231:1997;619-622.
9. Hla T., et al. Characterization of edg-2, a human homologue of the Xenopus maternal transcript G10 from endothelial cells. Biochim. Biophys. Acta. 1260:1995;227-229.
10. Bandoh K., et al. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274:1999;27776-27785.
11. Fukushima N., et al. Lysophospholipid receptors. Annu. Rev. Pharmacol. Toxicol. 41:2001;507-534.
12. Contos J.J., et al. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13384-13389.
13. Contos J.J., et al. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol. Cell. Biol. 22:2002;6921-6929.
14. Hooks S.B., et al. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent. J. Biol. Chem. 276:2001;4611-4621.
15. Lynch K.R., Macdonald T.L. Structure-activity relationships of lysophosphatidic acid analogs. Biochim. Biophys. Acta. 1582:2002;289-294.
16. McIntyre T.M., et al. From the cover: identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist. Proc. Natl. Acad. Sci. U. S. A. 100:2003;131-136.
17. Berger J., Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 53:2002;409-435.
18. Picard F., Auwerx J. PPAR(γ) and glucose homeostasis. Annu. Rev. Nutr. 22:2002;167-197.
19. Pagano R.E., et al. Intracellular translocation and metabolism of a fluorescent phosphatidic acid analogue in cultured fibroblasts. J. Biol. Chem. 258:1983;2034-2040.
20. Roberts R.Z., Morris A.J. Role of phosphatidic acid phosphatase 2a in uptake of extracellular lipid phosphate mediators. Biochim. Biophys. Acta. 1487:2000;33-49.
21. Gerrard J.M., Robinson P. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim. Biophys. Acta. 1001:1989;282-285.
22. Fourcade O., et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 80:1995;919-927.
23. Valet P., et al. α2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J. Clin. Invest. 101:1998;1431-1438.
24. Simon M.F., et al. Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production. J. Biol. Chem. 277:2002;23131-23136.
25. Eder A.M., et al. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin. Cancer Res. 6:2000;2482-2491.
26. Xie Y., et al. Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells. J. Biol. Chem. 277:2002;32516-32526.
27. 2+ signaling pathways. Curr. Biol. 8:1998;386-392.
28. Tokumura A., et al. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim. Biophys. Acta. 875:1986;31-38.
29. Umezu-Goto M., et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158:2002;227-233.
30. Stracke M.L., et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 267:1992;2524-2529.
31. Murata J., et al. cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J. Biol. Chem. 269:1994;30479-30484.
32. Bollen M., et al. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit. Rev. Biochem. Mol. Biol. 35:2000;393-432.
33. Stracke M.L., et al. Autotaxin is an N-linked glycoprotein but the sugar moieties are not needed for its stimulation of cellular motility. Melanoma Res. 5:1995;203-209.
34. Nam S.W., et al. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene. 19:2000;241-247.
35. Nam S.W., et al. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res. 61:2001;6938-6944.
36. Aoki J., et al. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J. Biol. Chem. 277:2002;48737-48744.
37. Sano T., et al. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J. Biol. Chem. 277:2002;21197-21206.
38. Belli S.I., Goding J.W. Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities. Eur. J. Biochem. 226:1994;433-443.
39. Brindley D.N., Waggoner D.W. Mammalian lipid phosphate phosphohydrolases. J. Biol. Chem. 273:1998;24281-24284.
40. Mandala S.M., et al. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death. Proc. Natl. Acad. Sci. U. S. A. 97:2000;7859-7864.
41. Jasinska R., et al. Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phosphate esters. Biochem. J. 340:1999;677-686.
42. Sciorra V.A., Morris A.J. Sequential actions of phospholipase D and phosphatidic acid phosphohydrolase 2b generate diglyceride in mammalian cells. Mol. Biol. Cell. 10:1999;3863-3876.
43. 2+ control lysophosphatidate signaling through EDG-2 receptors. J. Biol. Chem. 275:2000;27520-27530.
44. Tanyi, J.L. et al. The human lipid phosphate phosphatase-3 (hLPP-3) decreases the growth, survival, and tumorigenesis of ovarian cancer cells: Validation of the LPA signaling cascade as a target for therapy in ovarian cancer. Cancer Res. (in press).
45. Zhang N., et al. Mice mutant for Ppap2c, a homolog of the germ cell migration regulator wunen, are viable and fertile. Genesis. 27:2000;137-140.
46. Doren M.V., Lehmann R. Cell migration: don't tread on me. Curr. Biol. 7:1997;R148-R150.
47. Zhang N., et al. The Drosophila protein Wunen repels migrating germ cells. Nature. 385:1997;64-67.
48. Starz-Gaiano M., et al. Spatially restricted activity of a Drosophila lipid phosphatase guides migrating germ cells. Development. 128:2001;983-991.
49. Van Doren M., et al. HMG-CoA reductase guides migrating primordial germ cells. Nature. 396:1998;466-469.